We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+15.72%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$89.3M
AUM Growth
-$38M
(-30%)
Cap. Flow
-$44.1M
Cap. Flow
% of AUM
-49.33%
Top 10 Holdings %
Top 10 Hldgs %
77.23%
Holding
46
New
10
Increased
4
Reduced
8
Closed
18
Top Buys
| 1 |
Merck
MRK
|
+$8.6M |
| 2 |
United Therapeutics
UTHR
|
+$5.29M |
| 3 |
Addus HomeCare
ADUS
|
+$4.23M |
| 4 |
AbbVie
ABBV
|
+$3.32M |
| 5 |
UnitedHealth
UNH
|
+$2.94M |
Top Sells
| 1 |
Sanofi
SNY
|
+$11.8M |
| 2 |
GSK
GSK
|
+$8.99M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$8.74M |
| 4 |
AFAM
Almost Family Inc
AFAM
|
+$5.67M |
| 5 |
CFN
CAREFUSION CORPORATION
CFN
|
+$5.32M |
Sector Composition
| 1 | Healthcare | 90.04% |
| 2 | Financials | 2.5% |
| 3 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $19.1M | 21.39% |
28,091
-2,230
| -7% | -$1.41M |
|
|
PFNX
2
DELISTED
Pfenex Inc.
PFNX
| $10.4M | 11.66% |
653,393
+92,628
| +17% | +$1.02M |
|
|
3
Merck
MRK
$298B
| $8.34M | 9.33% |
+151,960
| New | +$8.6M |
|
|
4
United Therapeutics
UTHR
$22.4B
| $5.98M | 6.7% |
+34,700
| New | +$5.29M |
|
5
Cardinal Health
CAH
$53.9B
| $5.24M | 5.86% |
58,000
-4,100
| -7% | -$353K |
|
|
DMK
6
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $4.65M | 5.21% |
16,857
+163
| +1% | +$70.4K |
|
7
Johnson & Johnson
JNJ
$611B
| $4.53M | 5.07% |
45,000
+5,000
| +13% | +$508K |
|
|
8
Addus HomeCare
ADUS
$2.03B
| $4.36M | 4.88% |
+189,466
| New | +$4.23M |
|
|
9
AbbVie
ABBV
$432B
| $3.22M | 3.61% |
+55,000
| New | +$3.32M |
|
|
10
UnitedHealth
UNH
$386B
| $3.13M | 3.51% |
+26,500
| New | +$2.94M |
|
|
PETX
11
DELISTED
Aratana Therapeutics, Inc.
PETX
| $2.86M | 3.2% |
178,550
-146,870
| -45% | -$2.61M |
|
|
GTS
12
DELISTED
Triple-S Management Corporation
GTS
| $2.23M | 2.5% |
+118,144
| New | +$2.46M |
|
|
STML
13
DELISTED
Stemline Therapeutics, Inc.
STML
| $2.03M | 2.27% |
+140,000
| New | +$2.14M |
|
14
Heron Therapeutics
HRTX
$81.4M
| $2M | 2.23% |
+137,100
| New | +$1.55M |
|
|
FWP
15
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $1.91M | 2.14% |
9,636
-5,923
| -38% | -$961K |
|
|
AGRX
16
DELISTED
Agile Therapeutics
AGRX
| $1.89M | 2.12% |
102
-273
| -73% | -$4.78M |
|
|
BSTG
17
DELISTED
Biostage, Inc. Common Stock
BSTG
| $1.48M | 1.66% |
455,901
+320,639
| +237% | +$1.09M |
|
|
MRTX
18
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.37M | 1.53% |
+46,677
| New | +$1.09M |
|
19
SCYNEXIS
SCYX
$49M
| $1.27M | 1.42% |
1,910
-247
| -11% | -$203K |
|
20
TG Therapeutics
TGTX
$8.4B
| $1.19M | 1.33% |
76,924
-25,776
| -25% | -$390K |
|
21
Eledon Pharmaceuticals
ELDN
$313M
| $930K | 1.04% |
+508
| New | +$1.12M |
|
22
InspireMD
NSPR
$33.6M
| – | – |
0
| – | – |
|
23
Merit Medical Systems
MMSI
$4.24B
| $467K | 0.52% |
24,235
-68,837
| -74% | -$1.23M |
|
24
ADMA Biologics
ADMA
$2.06B
| – | – |
-245,930
| Closed | -$2.75M |
|
|
AKTX
25
Akari Therapeutics
AKTX
$23.5M
| – | – |
-23
| Closed | -$881K |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA